Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis

Multiple Sclerosis

Volumn 22, Issue 14, 2016, Pages 1850-1858

  Kim, Su Hyun ^a   Kwak, Kichang ^b   Jeong, In Hye ^a   Hyun, Jae Won ^a   Jo, Hyo Jin ^a   Joung, Aeran ^a   Yu, Eun Seung ^c   Kim, Ji Hee ^a   Lee, Sang Hyun ^a   Yun, Sooin ^c   Joo, Jungnam ^c   Lee, Dong Kyun ^b   Lee, Jong Min ^b   Kim, Ho Jin ^a  

^a National Cancer Center ^*  (South Korea)

^b Hanyang University   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

cognitive aspects; multiple sclerosis; Neuromyelitis optica

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; LAQUINIMOD; MYCOPHENOLATE MOFETIL; RITUXIMAB;

ADULT; AGE DISTRIBUTION; ARTICLE; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREVALENCE; PROSPECTIVE STUDY; SEX DIFFERENCE; TIME TO TREATMENT; VERBAL MEMORY; VISUAL MEMORY; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA;

EID: 85005922701     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458516636246     Document Type: Article

References (35)

1. Kim HJ, Paul F, Lana-Peixoto MA, et al. MRI characteristics of neuromyelitis optica spectrum disorder: An international update. Neurology 2015; 84: 1165-1173.
2. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
3. Kim SH, Kim W, Kook MC, et al. Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality. Mult Scler 2012; 18: 1340-1343.
4. Chiaravalloti ND, DeLuca J,. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151.
5. Blanc F, Noblet V, Jung B, et al. White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS ONE 2012; 7: e33878.
6. Blanc F, Zephir H, Lebrun C, et al. Cognitive functions in neuromyelitis optica. Arch Neurol 2008; 65: 84-88.
7. Saji E, Arakawa M, Yanagawa K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 2013; 73: 65-76.
8. Vanotti S, Cores EV, Eizaguirre B, et al. Cognitive performance of neuromyelitis optica patients: Comparison with multiple sclerosis. Arq Neuropsiquiatr 2013; 71: 357-361.
9. Liu Y, Wang J, Daams M, et al. Differential pattern of spinal cord and brain atrophy in NMOSD and MS. Neurology 2015; 84: 1465-1472.
10. Duan Y, Liu Y, Liang P, et al. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. Eur J Radiol 2012; 81: e110-e114.
11. Liu Y, Xie T, He Y, et al. Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica. Eur Radiol 2014; 24: 2334-2343.
12. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
13. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
14. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
15. Ahn HJ, Chin J, Park A, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 2010; 25: 1071-1076.
16. Shapiro AM, Benedict RH, Schretlen D, et al. Construct and concurrent validity of the Hopkins Verbal Learning Test-Revised. Clin Neurospychol 1999; 13: 348-358.
17. Shin MS, Park SY, Park SR, et al. Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test. Nat Protoc 2006; 1: 892-899.
18. Benton Al, Hamsher KdeS,. Multilingual aphasia examination. Iowa City, IA: University of Iowa, 1976.
19. Smith A,. Symbol digit modalities test. Los Angeles, CA: Western Psychological Services, 1991.
20. Gronwall DM,. Paced auditory serial-addition task: A measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-373.
21. Wechsler D,. Wechsler Adult Intelligence Scale-III: Administration and scoring manual. San Antonio, TX: The Psychological Corporation, 1997.
22. Reut A, Deloire M, Charré-Morin J, et al. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 2013; 80: 1501-1508.
23. Barbarotto R, Laiacona M, Frosio R, et al. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998; 19: 161-170.
24. Sled JG, Zijdenbos AP, Evans AC,. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998; 17: 87-97.
25. Collins DL, Neelin P, Peters TM, et al. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
26. Jeon S, Yoon U, Park JS, et al. Fully automated pipeline for quantification and localization of white matter hyperintensity in brain magnetic resonance image. Int J Imaging Syst Technol 2011; 21: 193-200.
27. Patti F, Amato MP, Trojano M, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: Baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779-788.
28. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
29. Benedict RH, Ramasamy D, Munschauer F, et al. Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201-216.
30. Zhang N, Li YJ, Fu Y, et al. Cognitive impairment in Chinese neuromyelitis optica. Mult Scler 2015; 21: 1839-1846.
31. Von Glehn F, Jarius S, Cavalcanti Lira RP, et al. Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler 2014; 20: 1189-1197.
32. Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: A multiparametric approach. Mult Scler 2012; 18: 817-824.
33. Rueda Lopes FC, Doring T, Martins C, et al. The role of demyelination in neuromyelitis optica damage: Diffusion-tensor MR imaging study. Radiology 2012; 263: 235-242.
34. Chiaravalloti MD, DeLuca J, Moore NB, et al. Treating learning impairments improves memory performance in multiple sclerosis: A randomized clinical trial. Mult Scler 2005; 11: 58-68.
35. Gmeindl L, Courtney SM,. Deconstructing spatial working memory and attention deficits in multiple sclerosis. Neuropsychology 2012; 26: 57-70.